This study focuses on the development of a system to integrate monthly outpatient cancer care data in the Unified National Health System (SUS). The system was modeled to retrace the treatment evolution in each cancer case and services output, with the following advantage: the system focuses on the cancer case, does not require knowledge by the user in order to handle the database, and allows updating the base as new data emerge. The results of direct queries in the system were identical to those obtained from direct inspection of the original database and those from another integration approach. The use of a tool with these characteristics by public administrators can help improve the quality of outpatient cancer care provided by the National Health System.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1590/s0102-311x2010000600007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
First-time use of electronic patient-reported outcome measures in a cluster randomized trial: a qualitative study.
J Patient Rep Outcomes
January 2025
Department of Health Sciences Ålesund, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Ålesund, Norway.
Background: Although there is clear evidence supporting the beneficial effects of regularly assessing patient-reported outcomes (PROs), the comprehensive integration of patient-reported outcome measures (PROMs) into routine cancer care remains limited. This study aimed to explore the facilitators and barriers encountered by principal investigators (PIs) (oncologists) and study nurses during the implementation of the Eir ePROM within a cluster randomized trial (c-RCT) in cancer outpatient clinics. Additionally, we sought to examine the influence of Eir on the working routines of the participants.
View Article and Find Full Text PDFWhat You Need to Know About: The Management of Malignant Pleural Effusion.
Br J Hosp Med (Lond)
December 2024
Department of Respiratory Medicine, Western General Hospital, Edinburgh, UK.
Malignant pleural effusion (MPE) is a common complication of malignancy and is regularly seen on the general medicine take. Diagnosis of MPE is indicative of advanced or metastatic disease and carries a poor prognosis, with median survival ranging from 3 to 12 months. Despite recent advancements in systemic anti-cancer treatment, the goal of management in MPE remains the palliation of symptoms.
View Article and Find Full Text PDFPrevalence of Insomnia and Related Factors Among Cancer Outpatients in China.
Nat Sci Sleep
January 2025
Department of Psychological Medicine, Fudan University Shanghai Cancer Center, Shanghai, 200032, People's Republic of China.
Background: The incidence of insomnia in cancer patients is significantly higher than in the general population. Chronic insomnia imposes pronounced physical and psychological burdens on cancer patients, affecting their quality of life and survival rate. This study aims to investigate insomnia in cancer patients and further analyze potentially related factors.
View Article and Find Full Text PDFPatients' Perceptions of the Efficacy, Safety, and Quality of the Evidence of Medicinal Cannabis: A Survey of Australian Cancer Patients.
Asia Pac J Clin Oncol
January 2025
Department of Medical Oncology, Gosford Hospital, Gosford, New South Wales, Australia.
Introduction: Despite the increased demand for medical cannabis (MC), MASCC guidelines state that there is insufficient evidence of its efficacy and safety. Although research has explored medical professionals' perceptions of MC, there is to our knowledge minimal research exploring patients' perceptions, particularly in an Australian cancer setting.
Methods: A survey of Australian cancer patients attending oncology outpatient clinics was performed.
'PHACE' on the 'face'.
BMJ Case Rep
January 2025
Paediatric Department, SJOG Midland Public Hospital, Midland, Western Australia, Australia.
Infantile haemangiomas are a common presentation in infants within the first few months of life. The majority of haemangiomas are benign; however, large haemangiomas (≥5 cm), especially those involving the face, may indicate a more serious underlying neurocutaneous disorder known as PHACE (Posterior fossa malformations, Haemangioma, Arterial anomalies, Coarctation of the aorta/Cardiac defects and Eye abnormalities) syndrome. The authors report an unusual case of possible PHACE syndrome in a young male toddler with a large facial haemangioma.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!